MECP2 duplication syndrome

MECP2 duplication syndrome
Other names	X-linked intellectual disability-hypotonia-recurrent Infections syndrome

This condition is due to MECP2 overexpression
Specialty	Medical genetics

MECP2 duplication syndrome (M2DS) is a rare disease that is characterized by severe intellectual disability and impaired motor function. It is an X-linked genetic disorder caused by the overexpression of MeCP2 protein.

YouTube Encyclopedic

1/5
Views:
11 814
1 513
595
820
1 083

Transcription

Signs and symptoms

Symptoms of M2DS include infantile hypotonia and failure to thrive, delayed psychomotor development, impaired speech, abnormal or absent gait, epilepsy, spasticity, gastrointestinal motility problems, recurrent infections, and genitourinary abnormalities.^[1]^[2]^[3] Many of those affected by M2DS also fit diagnostic criteria for autism.^[4] M2DS can be associated with syndromic facies, namely an abnormally flat back of the head, underdevelopment of the midface, ear anomalies, deep-set eyes, prominent chin, pointed nose, and a flat nasal bridge.^[4]

Cause

M2DS is one of the several types of X-linked intellectual disability. The cause of M2DS is a duplication of the MECP2 or Methyl CpG binding protein 2 gene located on the X chromosome (Xq28).^[5] The MeCP2 protein plays a pivotal role in regulating brain function. Increased levels of MECP2 protein results in abnormal neural function and impaired immune system.^[4] Mutations in the MECP2 gene are also commonly associated with Rett syndrome in females. Advances in genetic testing and more widespread use of Array Comparative Genomic Hybridization has led to increased diagnosis of MECP2 duplication syndrome.^[6] It is thought to represent ~1% of X-linked male mental disability cases.^[7] Females affected by this condition often do not show symptoms.^[4]

Diagnosis

Diagnosis is made based on genetic testing.^[4]

Management

Treatment is supportive and based on symptoms.^[4]

Epidemiology

The syndrome primarily affects young males.^[7] Preliminary studies suggest that prevalence may be 1.8 per 10,000 live male births. 50% of those affected do not live beyond 25 years of age, with deaths attributed to the impaired immune function.^[8]

History

M2DS was first described in 1999.^[4]

In a Nature article published on November 25, 2015, it was revealed that researchers at the Baylor College of Medicine, led by Dr. Huda Y. Zoghbi, have reversed MECP2 Duplication Syndrome in adult symptomatic mice using antisense therapy.^[9] Mice treated with an experimental ASO administered through the central nervous system had a reduction of MECP2 protein to normal levels and symptoms of hypoactivity, anxiety, and abnormal social behavior were resolved. Additionally, the seizure activity of the mice and abnormal EEG discharges were abolished. Initial studies demonstrated that reducing the MECP2 protein levels to the correct amount also normalized the expression of the other genes controlled by the MECP2 protein.^{[citation needed]}

References

^ "MECP2 duplication syndrome - Genetic and Rare Diseases Information Center (GARD) – an NCATS Program". rarediseases.info.nih.gov. Archived from the original on 2022-02-01. Retrieved 2017-10-26.
^ Ramocki, Melissa B.; Peters, Sarika U.; Tavyev, Y. Jane; Zhang, Feng; Carvalho, Claudia M. B.; Schaaf, Christian P.; Richman, Ronald; Fang, Ping; Glaze, Daniel G.; Lupski, James R.; Zoghbi, Huda Y. (2009). "Autism and other neuropsychiatric symptoms are prevalent in individuals withMeCP2duplication syndrome". Annals of Neurology. 66 (6): 771–782. doi:10.1002/ana.21715. ISSN 0364-5134. PMC 2801873. PMID 20035514.
^ Ramocki, Melissa B.; Tavyev, Y. Jane; Peters, Sarika U. (2010). "TheMECP2duplication syndrome". American Journal of Medical Genetics Part A. 152A (5): 1079–1088. doi:10.1002/ajmg.a.33184. ISSN 1552-4825. PMC 2861792. PMID 20425814.
^ ^a ^b ^c ^d ^e ^f ^g "MECP2 Duplication Syndrome".
^ Reference, Genetics Home. "MECP2 duplication syndrome". Genetics Home Reference.
^ "Van Wright Foundation". Van Wright Foundation.
^ ^a ^b Van Esch, H. (2011). "MECP2 Duplication Syndrome". Molecular Syndromology. 2 (3–5): 128–136. doi:10.1159/000329580. ISSN 1661-8777. PMC 3366699. PMID 22679399.
^ Van Esch, Hilde (7 June 1993). "MECP2 Duplication Syndrome". In Adam, Margaret P.; Ardinger, Holly H.; Pagon, Roberta A.; Wallace, Stephanie E.; Bean, Lora J.H.; Stephens, Karen; Amemiya, Anne (eds.). GeneReviews®. University of Washington, Seattle. PMID 20301461 – via PubMed.
^ Sztainberg, Yehezkel; Chen, Hong-mei; Swann, John W.; Hao, Shuang; Tang, Bin; Wu, Zhenyu; Tang, Jianrong; Wan, Ying-Wooi; Liu, Zhandong; Rigo, Frank; Zoghbi, Huda Y. (25 November 2015). "Reversal of phenotypes in MECP2 duplication mice using genetic rescue or antisense oligonucleotides". Nature. 528 (7580): 123–126. Bibcode:2015Natur.528..123S. doi:10.1038/nature16159. PMC 4839300. PMID 26605526.

External links

v t e Autism spectrum
Main	Causes Diagnosis Epidemiology Epigenetics Heritability History Memory Pathophysiology Sex and gender Societal and cultural aspects Therapies
Diagnoses	Pervasive developmental disorder Classic autism Asperger syndrome Pervasive developmental disorder not otherwise specified Childhood disintegrative disorder High-functioning autism
Associated conditions and phenomena	Alexithymia Autism and LGBT identities Autistic burnout Autistic catatonia Autistic masking Autistic meltdown Hyperlexia Late talker Monotropism Nonverbal autism Pathological demand avoidance Savant syndrome Special interests Stimming
Comorbid conditions	Avoidant/restrictive food intake disorder Attention deficit hyperactivity disorder Anxiety disorder obsessive–compulsive disorder Developmental coordination disorder Epilepsy Intellectual disability Sensory processing disorder Global developmental delay Verbal Dyspraxia
Associated syndromes	22q11.2 deletion syndrome Angelman syndrome CHARGE syndrome Cohen syndrome Cornelia de Lange syndrome Down syndrome Fetal valproate spectrum disorder Fragile X syndrome MECP2 duplication syndrome Neurofibromatosis type I Noonan syndrome PTEN hamartoma tumor syndrome Rett syndrome Smith–Lemli–Opitz syndrome Timothy syndrome Tuberous sclerosis complex Williams syndrome
Related issues	Autism rights movement Critical autism studies Double empathy problem Multiple complex developmental disorder Neurodiversity TEACCH program Violence and autism
Controversies	Facilitated communication Lancet MMR autism fraud MMR vaccine Rapid prompting method Thiomersal Chelation
Diagnostic scales	Autism Diagnostic Interview Autism Diagnostic Observation Schedule Autism-spectrum quotient Childhood Autism Rating Scale Gilliam Asperger's disorder scale
Lists	Autism-related topics Fictional characters Schools
Accommodations	Autism-friendly Sensory friendly

This page was last edited on 24 May 2024, at 23:51

Classification	D ICD-10: Q87.8 OMIM: 300260 MeSH: C537723 DiseasesDB: ddb34533
External resources	Orphanet: 85281

From Wikipedia, the free encyclopedia